Estimation of second line anti-tubercular drug susceptibility to <i>Mycobacterium tuberculosis</i> in clinical isolates. [PDF]
Iran J MicrobiolSudersanan H, Ravikumar NM, Mishra B.
europepmc +1 more source
Molecular docking and pharmacokinetics of benzimidazole-based FtsZ inhibitors for tuberculosis. [PDF]
Sci RepSonwane PN, Kumbhare MR.
europepmc +1 more source
Recent Progress in the Synthesis, Functionalization, and Biological Outlook of Pyrimidines. [PDF]
ACS OmegaMartis GJ, Mugali PS, Gaonkar SL.
europepmc +1 more source
Design, Synthesis, <i>In Vitro</i> Evaluation, Multitargeted Molecular Docking, and <i>In Silico</i> Analysis of Some Azo-Linked 1,3,4-Thiadiazole and 1,2,4-Triazole Heterocyclic Hybrids as Potent Antitubercular Agents. [PDF]
ACS OmegaPanigrahi D, Sahu SK.
europepmc +1 more source
Advancements in the design and development of pyrazoline-based antimycobacterial agents: an update and future perspectives. [PDF]
RSC AdvRakshit G +3 more
europepmc +1 more source
Tuberculosis-associated immune reconstitution inflammatory syndrome in a non-immunocompromised patient. [PDF]
Breathe (Sheff)Angelopoulos V +8 more
europepmc +1 more source
First episode of psychosis in a patient undergoing tuberculosis treatment. [PDF]
Breathe (Sheff)Murray J +5 more
europepmc +1 more source
Spontaneous splenic rupture: a sporadic presentation of tuberculosis-a case report. [PDF]
J Surg Case RepSambi ZA, Tsegay MA.
europepmc +1 more source
Isoniazid-Derived Hydrazones Featuring Piperazine/Piperidine Rings: Design, Synthesis, and Investigation of Antitubercular Activity. [PDF]
BiomoleculesÖzcan E +7 more
europepmc +1 more source